Search This Blog

Wednesday, November 6, 2019

PDL BioPharma EPS misses by $0.21, beats on revenue

PDL BioPharma (NASDAQ:PDLI): Q3 GAAP EPS of -$0.16 misses by $0.21.
Revenue of $44.2M (-34.9% Y/Y) beats by $10.34M.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)